Monographie - Cefiderocol sulfate tosylate

Poslední aktualizace :
05/12/2025

Cefiderocol sulfate tosylate

Chemický vzorec

Obchodní název

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Fetcroja

äpanÏlsko, Francie, Irsko, Itálie, MaÔarsko, Mexiko, NÏmecko, Švédsko, Velká Británie

Odkazy : Cefiderocol sulfate tosylate

	typ	uveřejnění
2093	Laboratoř	Cefiderocol (Fetcroja®)- Summary of Product Characteristics Shionogi B.V. 2020
4528	noviny	Lu J, Liu Q, Kupiec T, Vail H, Lunch L, Fam D, Vu N. Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration. Int J Pharm Compound 2021 ;25,1:52-61
4634	noviny	Loeuille G, D'Huart E, Vigneron J, Nisse YE, Beiler B, Polo C, Ayari G, Sacrez M, Demoré B, Charmillon A. Stability studies of 16 Antibiotics for Continuous Infusion in Intensive Care Units and for Performing Outpatient Parenteral Antimicrobial Therapy. Antibiotics 2022 ;11,4: 458
4801	noviny	Ruiz V, Yuwei Shen Y, Abouelhassan Y, Fouad A, Nicolau D, Kuti J. Physical compatibility of sulbactam/durlobactam with select intravenous drugs during simulated Y-site administration. Am J Health-Syst Pharm 2024 ;51,1:
4943	noviny	D'Huart E, Boutouha I, Berardi C, Vigneron J, Demore B, Charmillon A. Stability of Nine Time-Dependent Antibiotics for Outpatient Parenteral Antimicrobial Therapy (OPAT) Use Antibiotics 2025 Antibiotics 2025, 14(5),
4964	Laboratoř	GLUCONATE DE CALCIUM 10 % B.BRAUN, solution pour perfusion - Résumé des caractéristiques du produit. B BRAUN MELSUNGEN AG 2019

Mentions Légales